Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,401.87
(
0.01%
)
US TECH 100
28,356.80
(
0.24%
)
Dow Jones
49,593.20
(
-0.34%
)
Brent Oil
105.52
(
-0.23%
)
Bitcoin
79,724.68
(
-0.95%
)
News Focus
News Focus
Post# of 825912
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 92
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: sentiment_stocks post# 817784

Saturday, 03/14/2026 8:17:24 AM

Saturday, March 14, 2026 8:17:24 AM

Post# of 825912

The company has already run a P1 for Direct. Why on earth would they have to run another one?


A new IND, new API, new manufacturing and possibly a new adjuvant. That is a new drug, just because they still call it by the same name does not make it so.

I expect the trial, if ever launched, would be a P1/P2.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News